Participation bias in a randomised trial of screening for lung cancer

被引:77
|
作者
Hestbech, Mie Sara [1 ]
Siersma, Volkert [2 ]
Dirksen, Asger [3 ]
Pedersen, Jesper H. [4 ]
Brodersen, John [2 ]
机构
[1] Univ Copenhagen, Dept Gen Practice, DK-1014 Copenhagen, Denmark
[2] Univ Copenhagen, Res Unit Gen Practice, DK-1014 Copenhagen, Denmark
[3] Gentofte Univ Hosp, Dept Resp Med, DK-2900 Hellerup, Denmark
[4] Rigshosp, Dept Thorac Surg, DK-2100 Copenhagen, Denmark
关键词
Participation bias; Recruitment; Volunteering; Lung cancer; Mass screening; Screening-effect; Randomised controlled trial; Danish Lung Cancer Screening Trial (DLCST); SPIRAL COMPUTED-TOMOGRAPHY; SELF-SELECTION; NON-ATTENDANCE; HEALTHY-VOLUNTEERS; PHASE-I; PERSONALITY; CT; MAMMOGRAPHY; PREDICTORS; PROGRAM;
D O I
10.1016/j.lungcan.2010.12.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Participation bias might affect the results and the representability of randomised controlled trials. We investigated the degree of socio-demographic and psychosocial participation bias in the Danish Lung Cancer Screening Trial (DLCST). Methods: In DLCST the questionnaire COS-LC (Consequences of Screening in Lung Cancer) was used to measure the psychosocial aspects of screening. To investigate a difference with a comparable representative sample from the Danish population, we sent out an inclusion questionnaire to 3999 Danes in the age from 50 to 70 years randomly selected from the Central National Register. Those who completed the inclusion questionnaire and met the inclusion criteria from DLCST received the COS-LC. Those who completed the COS-LC-and thus formed a population sample comparable to DLCST - were compared to the DLCST participants on socio-demographics and psychosocial measures. Results: Participation rates were high among the comparable population sample: 75.3% completed the inclusion questionnaire and 77.4% of those who were eligible completed the COS-LC. The analyses revealed differences between the DLCST participants and the comparable population sample in the following socio-demographic aspects: social group, living alone, gender, age and geographical area. DLCST participants reported less negative psychosocial aspects than the comparable population sample. Conclusion: The present study has shown substantial socio-demographic and psychosocial participation bias in DLCST. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:325 / 331
页数:7
相关论文
共 50 条
  • [1] Informed participation in a randomised controlled trial of computed tomography screening for lung cancer
    van den Bergh, K. A. M.
    Essink-Bot, M. L.
    van Klaveren, R. J.
    de Koning, H. J.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (03) : 711 - 720
  • [2] Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial
    Crosbie, Philip A. J.
    Gabe, Rhian
    Simmonds, Irene
    Hancock, Neil
    Alexandris, Panos
    Kennedy, Martyn
    Rogerson, Suzanne
    Baldwin, David
    Booton, Richard
    Bradley, Claire
    Darby, Mike
    Eckert, Claire
    Franks, Kevin N.
    Lindop, Jason
    Janes, Sam M.
    Moller, Henrik
    Murray, Rachael L.
    Neal, Richard D.
    Quaife, Samantha L.
    Upperton, Sara
    Shinkins, Bethany
    Tharmanathan, Puvan
    Callister, Matthew E. J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (05)
  • [3] Attitudes to participation in a lung cancer screening trial: a qualitative study
    Patel, Deesha
    Akporobaro, Ajiri
    Chinyanganya, Nyasha
    Hackshaw, Allan
    Seale, Clive
    Spiro, Stephen G.
    Griffiths, Chris
    THORAX, 2012, 67 (05) : 418 - 425
  • [4] SCREENING FOR LUNG CANCER: A QUALITATIVE STUDY OF THE ACCEPTABILITY OF SCREENING AND PARTICIPATION IN THE LUNG-SEARCH TRIAL
    Akporobaro, A.
    Patel, D.
    Chinyanganya, N.
    Butawan, R.
    Hackshaw, A.
    Seale, C.
    Spiro, S.
    Griffiths, C.
    THORAX, 2010, 65 : A166 - A167
  • [5] Participation in lung cancer screening
    Baldwin, David R.
    Brain, Kate
    Quaife, Samantha
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (02) : 1091 - 1098
  • [6] Nodule management protocol of the NELSON randomised lung cancer screening trial
    Xu, Dong Ming
    Gietema, Hester
    de Koning, Harry
    Vernhout, Rene
    Nackaerts, Kristiaan
    Prokop, Mathias
    Weenink, Carla
    Lammers, Jan-Willem
    Groen, Harry
    Oudkerk, Matthijs
    van Klaveren, Rob
    LUNG CANCER, 2006, 54 (02) : 177 - 184
  • [7] Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial
    Aggestrup, Louise Mosborg
    Hestbech, Mie Sara
    Siersma, Volkert
    Pedersen, Jesper Hoist
    Brodersen, John
    BMJ OPEN, 2012, 2 (02):
  • [8] Physical activity and lung cancer screening (PALS): feasibility randomised controlled trial of exercise and physical activity in lung cancer screening
    Bonney, Asha
    Granger, Catherine L.
    Steinfort, Daniel
    Patrick, Cameron
    Marshall, Henry M.
    Fong, Kwun M.
    Manser, Renee
    RESPIRATORY RESEARCH, 2025, 26 (01)
  • [9] The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
    Field, John K.
    Duffy, Stephen W.
    Baldwin, David R.
    Brain, Kate E.
    Devaraj, Anand
    Eisen, Tim
    Green, Beverley A.
    Holemans, John A.
    Kavanagh, Terry
    Kerr, Keith M.
    Ledson, Martin
    Lifford, Kate J.
    McRonald, Fiona E.
    Nair, Arjun
    Page, Richard D.
    Parmar, Mahesh K. B.
    Rintoul, Robert C.
    Screaton, Nicholas
    Wald, Nicholas J.
    Weller, David
    Whynes, David K.
    Williamson, Paula R.
    Yadegarfar, Ghasem
    Hansell, David M.
    HEALTH TECHNOLOGY ASSESSMENT, 2016, 20 (40) : 1 - +
  • [10] Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
    Paci, Eugenio
    Puliti, Donella
    Pegna, Andrea Lopes
    Carrozzi, Laura
    Picozzi, Giulia
    Falaschi, Fabio
    Pistelli, Francesco
    Aquilini, Ferruccio
    Ocello, Cristina
    Zappa, Marco
    Carozzi, Francesca M.
    Mascalchi, Mario
    THORAX, 2017, 72 (09) : 825 - 831